Most Read Articles
Stephen Padilla, 06 Aug 2020
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
06 Aug 2020
Sodium–glucose cotransporter-2 (SGLT-2) inhibitors increase the risk for diabetic ketoacidosis (DKA) by almost threefold, with molecule-specific analyses suggesting a class effect, according to a study.
Stephen Padilla, 3 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.

Combined tests may improve severe AKI detection, prediction in children

Elaine Soliven
26 Nov 2019

Combining Renal Angina Index (RAI) and urinary Neutrophil Gelatinase Associated Lipocalin (uNGAL) tests may help clinicians to detect and predict the development of severe acute kidney injury (AKI) in children admitted to the PICU*, according to a study presented at ASN Kidney Week 2019.

“Integration of the RAI and uNGAL assessments can be used early in the PICU course to identify patients truly at risk for AKI and its associated morbidity,” said study lead author Kelli Krallman, a research nurse at Cincinnati Children's Hospital Medical Center in Cincinnati, Ohio, US.

Researchers conducted a study involving 627 children who underwent an automated RAI assessment within 12 hours after PICU admission. Of these, 63 children were found to be RAI-positive (defined as an RAI score of ≥8) and were referred for an additional uNGAL assessment (cut-off value of at least 150 ng/mL). [ASN Kidney Week 2019, abstract SA-OR017]

On day 2–4 in the PICU, patients who were RAI-positive children had a significantly higher rate of severe AKI compared with those who were RAI-negative (38.0 percent vs 1.8 percent; p<0.001).

When an additional uNGAL test was performed, a significantly higher rate of severe AKI was also observed among patients positive for both RAI and uNGAL (55.5 percent vs 17.6 percent; p<0.0001) compared with patients tested negative for both RAI and uNGAL.

Of note, the need for renal replacement therapy was found to be higher among the RAI-positive group compared with the RAI-negative group (13.0 percent vs 0.4 percent; p<0.001).

RAI-positive patients also experienced a significantly longer stay in the PICU (4.6 vs 3.1 days; p<0.02) and hospital (17.8 vs 7.5 days; p<0.001) than the RAI-negative patients.

However, there was no difference in the occurrence of fluid overload between the RAI-positive and RAI-negative patients (p=0.14 vs p=0.11).

“The RAI alone continues to be a good rule-out test for severe AKI in the PICU, and [the] addition of uNGAL is promising for improved severe AKI prediction,” said the researchers, recommending that “additional research needs to be conducted on a larger sample size to better assess the clinical relevance of the RAI-[u]NGAL model in predicting severe AKI and other relevant outcomes”.

 

*PICU: Paediatric intensive care unit

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 06 Aug 2020
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
06 Aug 2020
Sodium–glucose cotransporter-2 (SGLT-2) inhibitors increase the risk for diabetic ketoacidosis (DKA) by almost threefold, with molecule-specific analyses suggesting a class effect, according to a study.
Stephen Padilla, 3 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.